Works matching IS 15747891 AND DT 2020 AND VI 14 AND IP 3


Results: 13
    1
    2
    3

    miRNAs as radio‐response biomarkers for breast cancer stem cells.

    Published in:
    Molecular Oncology, 2020, v. 14, n. 3, p. 556, doi. 10.1002/1878-0261.12635
    By:
    • Griñán‐Lisón, Carmen;
    • Olivares‐Urbano, María Auxiliadora;
    • Jiménez, Gema;
    • López‐Ruiz, Elena;
    • Val, Coral;
    • Morata‐Tarifa, Cynthia;
    • Entrena, José Manuel;
    • González‐Ramírez, Amanda Rocío;
    • Boulaiz, Houria;
    • Zurita Herrera, Mercedes;
    • Núñez, María Isabel;
    • Marchal, Juan Antonio
    Publication type:
    Article
    4
    5
    6
    7
    8

    Issue Information.

    Published in:
    Molecular Oncology, 2020, v. 14, n. 3, p. 485, doi. 10.1002/1878-0261.12510
    Publication type:
    Article
    9

    NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers.

    Published in:
    Molecular Oncology, 2020, v. 14, n. 3, p. 504, doi. 10.1002/1878-0261.12621
    By:
    • Bertucci, François;
    • Rypens, Charlotte;
    • Finetti, Pascal;
    • Guille, Arnaud;
    • Adélaïde, José;
    • Monneur, Audrey;
    • Carbuccia, Nadine;
    • Garnier, Séverine;
    • Dirix, Piet;
    • Gonçalves, Anthony;
    • Vermeulen, Peter;
    • Debeb, Bisrat G.;
    • Wang, Xiaoping;
    • Dirix, Luc;
    • Ueno, Naoto T.;
    • Viens, Patrice;
    • Cristofanilli, Massimo;
    • Chaffanet, Max;
    • Birnbaum, Daniel;
    • Van Laere, Steven
    Publication type:
    Article
    10
    11
    12

    High CD206 levels in Hodgkin lymphoma‐educated macrophages are linked to matrix‐remodeling and lymphoma dissemination.

    Published in:
    Molecular Oncology, 2020, v. 14, n. 3, p. 571, doi. 10.1002/1878-0261.12616
    By:
    • Arlt, Annekatrin;
    • Bonin, Frederike;
    • Rehberg, Thorsten;
    • Perez‐Rubio, Paula;
    • Engelmann, Julia C.;
    • Limm, Katharina;
    • Reinke, Sarah;
    • Dullin, Christian;
    • Sun, Xueni;
    • Specht, Rieke;
    • Maulhardt, Markus;
    • Linke, Franziska;
    • Bunt, Gertrude;
    • Klapper, Wolfram;
    • Vockerodt, Martina;
    • Wilting, Jörg;
    • Pukrop, Tobias;
    • Dettmer, Katja;
    • Gronwald, Wolfram;
    • Oefner, Peter J.
    Publication type:
    Article
    13

    Sacituzumab govitecan, an antibody‐drug conjugate targeting trophoblast cell‐surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo.

    Published in:
    Molecular Oncology, 2020, v. 14, n. 3, p. 645, doi. 10.1002/1878-0261.12627
    By:
    • Perrone, Emanuele;
    • Manara, Paola;
    • Lopez, Salvatore;
    • Bellone, Stefania;
    • Bonazzoli, Elena;
    • Manzano, Aranzazu;
    • Zammataro, Luca;
    • Bianchi, Anna;
    • Zeybek, Burak;
    • Buza, Natalia;
    • Tymon‐Rosario, Joan;
    • Altwerger, Gary;
    • Han, Chanhee;
    • Menderes, Gulden;
    • Huang, Gloria S.;
    • Ratner, Elena;
    • Silasi, Dan‐Arin;
    • Azodi, Masoud;
    • Hui, Pei;
    • Schwartz, Peter E.
    Publication type:
    Article